The 18th International Symposium on Critical Care and Emergency Medicine 2011

Dear Colleagues,

It is our sincere pleasure to invite you to take part in the 18th International Symposium on Critical Care & Emergency Medicine 2011 which will be held in Discovery Kartika Plaza Hotel, Kuta, Bali, Indonesia, and this year we have a special meeting for nurses ie International Symposium on Critical Care & Emergency Nursing 2011 in Bali Rani Hotel, Kuta, Bali, Indonesia. This meeting is designed to advance the knowledge and expertise of nurses in critical care settings and to foster communication and collaboration among colleagues in the critical care community. We have discuss, debate and analyze how the nursing profession can respond through advanced practice to changing environments to meet the demands placed on the critical care and emergency system.

It is an honor for us to continuing the success of International Symposium on Shock and Critical Care.

The Symposium is aimed to present the most advanced scientific information, promote global exchange of recent achievements in research and clinical experience. Here we can share and discuss in emergency and critical care practice issues. We invite renowned world-class experts from Australia, China, France, Hong Kong, Italy, Korea, Malaysia, New Zealand, Saudi Arabia, Egypt, Singapore, United Kingdom, and USA.

From year to year, we have growing numbers of participants. We believe that the secret of this success is the friendships among enthusiast people joined by the common wish of discussing, sharing the experiences with the colleagues. It’s a great opportunity to stay connected with their peers, learn-share opinions and find answers.

We invite you to participate in the 18th International Symposium on Critical Care & Emergency Medicine 2011 and we look forward to welcome you in the beautiful city of Bali.

Sincerely yours,

Tri Wahyu Murni
Chairperson of Organizing Committee
Joseph Varon
Chairperson of Scientific Committee


CVVHD, impedance cardiography and critical care nephrology: a case study of chronic myeloid leukemia-associated ARF

Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by clonal expansion of myeloid cells, with the aberrant BCR-ABL fusion gene as the pathognomonic cytogenetic anomaly. (1) Leukemic cells are minimally invasive and their proliferation is largely confined to hematopoietic tissues: primarily to the blood, bone marrow, spleen and liver. (2) Although rare, renal involvement in CML has also been reported. (3-5)
In addition to parenchymal infiltration of leukemia cells, CML can adversely impact on the kidneys in several ways. (4) Acute renal failure (ARF) of the renal origin, in turn, is associated with increased hospital mortality of CML patients. (6)


Statin use and morbidity outcomes in septic shock patients: a retrospective cohort study

Sepsis is a significant burden on the health care system and is among the top ten leading causes of death in the United States. (1) The incidence of sepsis is rising substantially due to an aging population, increasing resistance among microorganisms, higher prevalence of immunocompromised patients, increasing number of patient comorbidities and more high risk surgeries being performed. One in four cases of sepsis progresses to severe sepsis or septic shock, conditions characterized by organ dysfunction and hypotension. (2) Septic shock carries a high mortality rate, adversely affects quality of life after hospital discharge and is a significant financial burden to the health care system.


Transfusion practices among the neurosurgical community of Puerto Rico

Anemia is a common problem in the intensive care unit (ICU); almost 95% of patients admitted to an ICU have a hemoglobin (Hb) level below normal by day 3. (1) Serious effects of anemia include increased risk of cardiac related morbidity and mortality, as well as generalized decrease in oxygen carrying capacity. More than 50% of the patients admitted to the ICUs will receive blood transfusions. (1) Although anemia can easily be corrected with packed red blood cells (PRBC), multicenter, randomized, controlled trials and large, prospective, observational studies have shown that liberal use of blood transfusions to be ineffective and potentially harmful. (1-3)


Clinical presentation and outcome of patients diagnosed with active pulmonary tuberculosis in a large critical care unit

Tuberculosis can be regarded as a global pandemic with almost 9 million new cases and approximately 2 million deaths each year. (1) An estimated one-third of the population of the world is infected with Mycobacterium tuberculosis, and the resultant disease represents a major public health problem. (2) Endemic infection is a major contributor to the annual death rate across the globe. The high morbidity and mortality of tuberculosis is the source of major medical and social problems, especially in developing countries.
It is ranked as the seventh highest cause of morbidity worldwide, and ranks even higher in emerging nations. (3,4)